New Delhi: Minister of Health Junior India, Bharati Pravin Pawar, gave Rajya Sabha three different number sets for Covaxin monthly output, and two for covishield, on the same day in response to questions.
These two questions were asked by the same member.
And the number quoted by the Minister did not match what had previously been by the government told the Supreme Court in a statement.
On July 20, in response to questions from Congress MP Malikarjun Kharge, Pawar said the average monthly production capacity of Covishield by the Serum Institute of India was 11 doses of Crore and Kovaxin dosage Bharat Biotech 2.5 Crore.
He continued to add that “as communicated by producers, the production capacity of the Covishield monthly vaccine is planned to increase from 11 doses of crore per month to more than 12 doses of crore per month and the Covaxin production capacity is planned to increase from 2.5 doses of crore per month 5.8 Crore Dosage Per Month.
“Responding to questions from BJP MP TG Venkatesh from Andhra on the same day, Pawar said” The estimated amount of production is around 130 million (13 crore) doses / month “for covishield and for covaxin” estimates the amount of production is around 17.5 million.
(1.75 crore) dosage / month.
“For other questions from Kharge the same day, about the MOU signed between ICMR and Bharat Biotech, Pawar said the efforts of the biotechnology department to increase covaxin production” expected to be able to Increase the production of one crore for up to ten years.
Crore in the coming months “.
Incidentally, the government affidavit submitted at the Supreme Court on May 9 has stated: “Serum India Institute Ltd has increased production from 5 doses of crore per month to 6.5 doses of crore per month and further ramp-up is expected to be 2021.
Bharat Biotech Intl Ltd.
has increased production of 90 lakh / month 2 dosage / month and further improvement is expected to up to 5.5 crore / month in 2021.
“While the Serum Institute seems to have increased production to 11 crores (or more) as expected at May, the actual production capacity of Bharat Biotech seems to be a mystery for the government.
In Affidavit May, the government has stated that it has a production capacity of approximately 2 doses of crore per month covaxin.
But now it puts anything between 1 crore up to 2.5 doses of crore per month.
In the previous written statement submitted on April 29, the government has stated that the production of Covaxin Bharat Biotech will rise from 90 lakh / month to 1 crore and further to 5 doses / month before July 2021.
With that estimate, Bharat Biotech’s capacity must be double Of the 2.5 crores, such as claimed in one response at Rajya Sabha on July 20, to touch the dose of 5 crores at the end of July or up more than five times from 1.75 crore doses according to another response.
According to a written statement on June 26, the Government at the Supreme Court, a total of 51.6 doses of crore will be available at the end of July.
These include eight doses of Covaxin Crore to be supplied from the end of May to July.
It also revealed that 2.55 doses of crore covaxin have been given until May 21.
According to the Cowin website, from January 16, when the vaccination drive was launched, until now, nearly 5.1 doses of Covaxin Crore have been given.
So around 2.6 crore doses have been given in two months since May 21, or around 1.3 crores per month, a definite increase over the previous months but far from eight expected crore doses.
On June 26 Affidavit the Supreme Court, the availability of government projections of 135 covid vaccine crore doses from August to December 2021 included 40 doses of covaxin crore, or around 8 doses of crore per month.
Covid-19: What is the output of Indian vaccines? There is no definite answer
